Bipoc News

BIPOC . NEWS : education

News & Opinion

‘Miracle’ weight-loss drugs could have reduced health disparities. Instead they got worse

Donna Cooper holds up a dose of Wegovy, a drug used for weight loss.

Wegovy is part of a new generation of weight-loss medications that made some doctors optimistic about reversing longstanding racial and ethnic disparities in obesity. So far, the pricey drugs seem to have made those disparities worse. (Amanda Andrade-Rhoades / Associated Press)

For the record:
9:10 p.m. April 15, 2024: An earlier version of this article misspelled the name of Dr. Serena Jingchuan Guo of the University of Florida as Jigchuan.

The American Heart Assn. calls them “game changers.”

Oprah Winfrey says they’re “a gift.”

Science magazine anointed them the “2023 Breakthrough of the Year.”

Americans are most familiar with their brand names: Ozempic, Wegovy, Mounjaro, Zepbound. They are the medications that have revolutionized weight loss and raised the possibility of reversing the country’s obesity crisis.

Obesity — like so many diseases — disproportionately affects people in racial and ethnic groups that have been marginalized…

Read more…

Leave a Comment

Your email address will not be published. Required fields are marked *